A blood clot is part of a bigger picture.
Why I stopped treating mine as a one-time event.
Start here
A Blood Clot Is Part of a Bigger Picture
What my vascular team told me, and why it changed my questions.
Read the transcript
REPLACE-WITH-TRANSCRIPT
A Blood Clot Is a Cardiovascular Diagnosis
Blood clots in the veins, called venous thromboembolism (VTE), are often described as the third leading cardiovascular diagnosis, after heart attack and stroke.1
Same vascular system. Some of the same risk factors. That reframed how I think about life after a clot.
I Thought I Misheard My Surgeon
At my final vascular visit, I shared two goals: to improve my cardiovascular health and address the damage multiple clots had done, and to figure out how to navigate menopause and aging well on an anticoagulant.
The answer was “focus on the cardiovascular guidelines.” Heart health? What did that have to do with a blood clot?
It turns out a lot. I had been looking at it through a narrow lens, and this wider one is why Speaking of Blood Clots looks the way it does.
How the Picture Fits Together
We tend to talk about clots in veins and plaque in arteries as two different problems. Researchers are asking whether they should be. Prevention efforts have broadened from risks tied to hospital stays toward heart-healthy lifestyles, which challenged the old view of venous and arterial clots as separate conditions.2
The overlap is real, but it isn’t complete. Apart from obesity, the usual cardiovascular risk factors were less strongly linked to clots than to heart disease.2 So this isn’t “a clot is just heart disease.” It’s that the two share more ground than most of us were told.
Obesity is a recognized risk factor for clots, and researchers link it to inflammation and to the body making more clotting factors.3 It is also one of the risk factors that can sometimes be influenced, which is a conversation for you and your care team. Naming a risk factor isn’t blaming anyone for it.
Obesity isn’t only a number on a scale, and where the fat sits may matter too. Visceral fat is the fat packed around your organs, and it adds to belly size. In one large study, waist size tracked with clot risk even after accounting for overall weight.4 In another, weight, waist size and body fat measures predicted a first clot about equally.5 Researchers are still sorting out what location adds.
Why It Matters
After a clot, the picture gets wider in a way worth knowing about. A Danish study followed 25,199 people with a deep vein thrombosis (DVT, a clot in a leg vein) and 16,925 with a pulmonary embolism (PE, a clot in the lung), none with known cardiovascular disease, and compared them with 163,566 people from the general population. In the first year, their risk of a cardiovascular event, like a heart attack, was higher.6
the risk of a heart attack in the first year after a DVT.
the risk of a heart attack in the first year after a PE.
Stroke risk was higher too: 2.2 times after a DVT and 2.9 times after a PE. Over the next 20 years the increase was smaller, and it looked similar whether the clot was provoked (a clear trigger, like surgery) or unprovoked (none found).6
What this doesn’t tell us: these are relative risks, which compare one group with another, so they show a link, not your personal odds. They also watched what happened and didn’t test what to do about it. Your care team can put the numbers in the context of your own history.
Telling Isn’t Teaching
One hematologist described how he and his colleagues approach it at a 2024 hematology meeting: when obesity is a risk factor, doctors mention diet and exercise, then “sort of shrug our shoulders.”7
In my hospital notes, obesity and lifestyle appeared on my diagnosis list eight times. Nobody explained why it mattered, gave me tools, or referred me anywhere. I found a registered dietitian myself, after reading the research on my own, and brought what I learned to my care team. Telling someone isn’t the same as teaching them. Whether a doctor expects you to act on a risk factor shouldn’t decide whether you get the information and a plan.
A risk factor can’t be important enough to document eight times and unimportant enough to leave out of the plan.
What This Changes
You don’t have to become a different person or add more worry. You get to ask better questions. At your next visit, try:
Beyond the clot, what does my cardiovascular health look like, and which numbers should I know?
For any risk factor that’s ongoing, what’s the plan, and who can help me with it, like a registered dietitian?
Get the free guideSources
Links open in a new tab.
- American Heart Association. Venous thromboembolism. Read the page (opens in a new tab) Back to text
- Gregson J, et al. Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol. 2019. Read the paper (opens in a new tab) Cohort data from the Emerging Risk Factors Collaboration and UK Biobank. Back to text
- Dicks AB, Moussallem E, Stanbro M, Walls J, Gandhi S, Gray BH. A comprehensive review of risk factors and thrombophilia evaluation in venous thromboembolism. J Clin Med. 2024;13(2):362. Read the paper (opens in a new tab) Open-access review. Back to text
- Hagan KA, Harrington LB, Kim J, Lindström S, Camargo CA Jr, Grodstein F, Kabrhel C. Adiposity throughout the life course and risk of venous thromboembolism. Thromb Res. 2018;172:67-73. Read the paper (opens in a new tab) Nurses’ Health Studies and Health Professionals Follow-Up Study. Back to text
- Caiano LM, Costanzo S, Panzera T, Di Castelnuovo A, de Gaetano G, Donati MB, Ageno W, Iacoviello L. Association between body mass index, waist circumference, and relative fat mass with the risk of first unprovoked venous thromboembolism. Nutr Metab Cardiovasc Dis. 2021;31(11):3122-3130. Read the paper (opens in a new tab) Italian Moli-sani cohort. Back to text
- Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet. 2007;370(9601):1773-1779. Read the abstract (opens in a new tab) Nationwide Danish registry study. Relative risks, not absolute risks. Back to text
- Ingram I. GLP-1 drugs tied to reduced risk of dangerous blood clots. MedPage Today. December 8, 2024. Reports remarks by Patell R at the American Society of Hematology annual meeting. Read the article (opens in a new tab) News coverage of a conference talk, quoted only for the speaker’s description of current practice. The drug study he presented is not cited here. Back to text
